Bendamustine versus chlorambucil as first-line treatment in B cell chronic lymphocytic leukemia: An updated analysis from an international phase III study. 30. Mai 2008 Knauf, W.U., Lissitchkov, T., Aldaoud, A., Liberati, A., Loscertales, J., Herbrecht, R., Juliusson, G., Postner, G., Gercheva, L., Goranov, S., Becker, M., Hoeffken, K., Huguet, F., Foa, R., Merkle, K., Montillo, M., 2008. Blood 112(11), 2091. Abstract Results of the first planned analysis of the TEAM (tamoxifen exemestane adjuvant multinational) prospective randomized phase III trial in hormone sensitive postmenopausalearly breast cancer. Jones, S.E., Seynaeve, C., Hasenburg, A., Rea, D., Vannetzel, J.M., Paridaens, R., Markopoulos, C., Hozumi, Y., Putter, H., Hille, E., Kieback, D.G., Asmar, L., Smeets,… Weiterlesen Quality of life in relation to hormonal treatment of postmenopausal women in the Dutch subset of the TEAM Trial. van Nes, J., Voskuil, D., Putter, H., van Leeuwen, F., Junggeburt, J., Hille, E., de Haes, H., van de Velde, C., 2008. Cancer Res 69(2… Weiterlesen